Sixteen tumors were strongly PSMA-positive on tumor vessels (as expressed by a combined score of percentage and intensity of PSMA reactivity), 5 were moderately positive and 5 had absent/mild positivity. This evidence concerns the gene FOLH1 and neoplasm.